GlassScriptPhysician profile
Sartaj Hans
NPI 1407893324
$3,818.00
in general payments reported to CMS, 2019-2025
8 companies · $2,736 in 2025
The $2,736 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.43 · 2020: $227 · 2021: $384 · 2022: $109 · 2023: $145 · 2024: $178 · 2025: $2,736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,128 · Food and Beverage: $932.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,127.66 |
| Food and Beverage | $931.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,401.88 | 2021-2025 | Versacross Connect Laac Access Solution, Versacross Access Solution, Watchman Flx |
| Abiomed | $401.77 | 2021-2025 | Impella |
| Abbott Laboratories | $323.38 | 2020-2025 | Amplatzer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $259.28 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $124.98 | 2023 | Xarelto |
| Penumbra, INC. | $122.81 | 2022-2025 | Indigo System |
| Cardiovascular Systems INC. | $120.49 | 2021 | |
| Medtronic, INC. | $63.41 | 2025 | Micra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sartaj Hans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.